BCAB
BioAtla, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.74
+2.66%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-52.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Vasquez Christian · officer: Chief Financial Officer | F-InKind | 71 | $1.69 |
| Sep 2, 2026 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 134 | $1.69 |
| Sep 2, 2026 | SHORT JAY M PHD · director, officer: Chief Executive Officer | F-InKind | 259 | $1.69 |
| Jun 5, 2026 | SHORT JAY M PHD · director, officer: Chief Executive Officer | F-InKind | 639 | $0.17 |
| Jun 5, 2026 | Vasquez Christian · officer: Chief Financial Officer | F-InKind | 175 | $0.17 |
| Jun 5, 2026 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 360 | $0.17 |
| Jun 5, 2026 | SHORT JAY M PHD · director, officer: Chief Executive Officer | F-InKind | 259 | $3.93 |
| Jun 5, 2026 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 134 | $3.93 |
| Jun 5, 2026 | Vasquez Christian · officer: Chief Financial Officer | F-InKind | 82 | $3.93 |
| Mar 12, 2026 | SHORT JAY M PHD · director, officer: Chief Executive Officer | A-Award | 430,000 | $0.00 |
| Mar 12, 2026 | Vasquez Christian · officer: Chief Financial Officer | A-Award | 240,000 | $0.00 |
| Mar 12, 2026 | Sievers Eric · officer: Chief Medical Officer | A-Award | 240,000 | $0.00 |
| Mar 2, 2026 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 3,140 | $0.25 |
| Mar 2, 2026 | SHORT JAY M PHD · director, officer: Chief Executive Officer | F-InKind | 7,728 | $0.25 |
| Mar 2, 2026 | Vasquez Christian · officer: Chief Financial Officer | F-InKind | 1,802 | $0.25 |
| Mar 2, 2026 | WALDRON RICHARD A · officer: Former Chief Financial Officer | F-InKind | 2,729 | $0.25 |
| Dec 1, 2025 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 2,729 | $0.90 |
| Dec 1, 2025 | Vasquez Christian · officer: See Remarks | F-InKind | 1,566 | $0.90 |
| Dec 1, 2025 | SHORT JAY M PHD · director, 10 percent owner, officer: Chief Executive Officer | F-InKind | 6,347 | $0.90 |
| Dec 1, 2025 | WALDRON RICHARD A · officer: Chief Financial Officer | F-InKind | 2,371 | $0.90 |
| Sep 2, 2025 | WALDRON RICHARD A · officer: Chief Financial Officer | F-InKind | 2,371 | $0.46 |
| Sep 2, 2025 | Sievers Eric · officer: Chief Medical Officer | F-InKind | 2,729 | $0.46 |
| Sep 2, 2025 | Vasquez Christian · officer: See Remarks | F-InKind | 1,566 | $0.46 |
| Sep 2, 2025 | SHORT JAY M PHD · director, 10 percent owner, officer: Chief Executive Officer | F-InKind | 6,347 | $0.46 |
| Jun 18, 2025 | GRAY MARY ANN · director | A-Award | 23,500 | $0.00 |
| Jun 18, 2025 | Moran Susan · director | A-Award | 23,500 | $0.00 |
| Jun 18, 2025 | Williams Eddie · director | A-Award | 23,500 | $0.00 |
| Jun 18, 2025 | STEINMAN LAWRENCE · director | A-Award | 23,500 | $0.00 |
| Jun 18, 2025 | MCBRINN SYLVIA · director | A-Award | 23,500 | $0.00 |
| Jun 18, 2025 | Smith Scott Andrew · director | A-Award | 23,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 7Reduced 10Sold out 34
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | Increased | 5,406,345 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,756,674 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,649,252 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,233,919 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 689,182 | May 15, 2026 |
| DEUTSCHE BANK AG\ | Reduced | 525,352 | May 6, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 510,514 | May 14, 2026 |
| BLACKROCK, INC. | Reduced | 480,931 | May 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 473,575 | May 15, 2026 |
| UBS GROUP AG | Increased | 375,569 | May 5, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 273,427 | May 8, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 228,107 | May 18, 2026 |
| STATE STREET CORP | Unchanged | 151,377 | May 15, 2026 |
| NORTHERN TRUST CORP | Unchanged | 103,494 | May 14, 2026 |
| JANE STREET GROUP, LLC | Reduced | 93,342 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026